Cargando…

Gadolinium-based contrast agents for imaging of the central nervous system: A multicenter European prospective study

Contrast-enhanced MR (CE-MR) imaging is required to improve lesion detection and characterization and to increase diagnostic confidence. This study aims to evaluate the safety, effectiveness, and usage patterns of recently introduced Clariscan(TM) (gadoterate meglumine) and other macrocyclic gadolin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heshmatzadeh Behzadi, Ashkan, McDonald, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410688/ https://www.ncbi.nlm.nih.gov/pubmed/36042629 http://dx.doi.org/10.1097/MD.0000000000030163

Ejemplares similares

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

MRI and CT contrast media extravasation: A systematic review
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2018)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Prospective multicenter assessment of patient preferences for properties of gadolinium-based contrast media and their potential socioeconomic impact in a screening breast MRI setting
por: Woolen, Sean A., et al.
Publicado: (2021)

Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)

Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study
por: Jakobsen, Jarl Åsbjørn, et al.
Publicado: (2021)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
por: Patil, Rameshwar, et al.
Publicado: (2020)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes
por: Vergauwen, Evelynn, et al.
Publicado: (2018)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Bladder diverticuli following injection of onabotulinum toxin A in a patient with multiple sclerosis and autosomal dominant polycystic kidney disease
por: Raza, Syed Imran, et al.
Publicado: (2018)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
por: Clough, Thomas J., et al.
Publicado: (2019)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines
por: Khawaja, Aurang Z., et al.
Publicado: (2015)

Gadolinium‐based contrast agent exposures and physical and cognitive disability in multiple sclerosis
por: Nakamura, Kunio, et al.
Publicado: (2022)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
por: Kerget, Bugra, et al.
Publicado: (2018)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval
por: Gress, Kyle L, et al.
Publicado: (2020)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Cruje, Charmainne, et al.
Publicado: (2021)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Gadolinium as a contrast agent for infusion sialograms in patients with iodine allergy
por: Sabotin, Ryan P., et al.
Publicado: (2023)

A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents
por: Zheng, Huanhuan, et al.
Publicado: (2022)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
por: Rogosnitzky, Moshe, et al.
Publicado: (2016)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
por: Davies, Julie, et al.
Publicado: (2022)

The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients
Publicado: (2022)

Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review
por: Iyad, Nebal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h2slsu9ujnuie8gav95qokm6o4